OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease

HTML

Year: 2010
Type: article
Study design: Clinical Trial
Source: Clinical Neuropharmacology
DOI: 10.1097/wnf.0b013e3181cb577a
Authors: Eric R. Siemers, Stuart Friedrich, Robert A. Dean, Celedon R. Gonzales, Martin R. Farlow, Steven M. Paul, Ronald B. DeMattos
Institutions: Eli Lilly (United States), Indiana University Indianapolis, Indiana University School of Medicine
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: solanezumab, amyloid-beta, Alzheimer's disease, monoclonal antibodies, passive immunization, drug safety, infusion reactions, plasma amyloid-beta, cerebrospinal fluid amyloid-beta, gadolinium-enhanced MRI, cognitive function
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2013078308
FWCI: 7.798
Cites: 33
Cited by: 209
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms